Livestock
More than 45 percent of Boehringer Ingelheim Animal Health business’s global revenue comes from our livestock business (poultry, ruminant, swine and Veterinary Public Health), driven by innovative parasiticides, vaccines and therapeutics, as well as our history of partnership with livestock producers, livestock veterinarians, government officials and NGOs.
We bring innovative health solutions to our customers to prevent disease in livestock. In doing so, we help livestock producers produce more high quality food using fewer natural resources.
We also strive to address some of the most pressing challenges facing our livestock customers, such as the need to cost-effectively produce more protein to feed the world's growing population. By 2050, the global population will reach 9.7 billion people, with a significant increase in the middle class, and substantial growth in emerging markets like Africa and Asia. As a result, the demand for animal protein is expected to increase by 70 percent.
In response to a growing public health concern over antibiotic resistance and the need for food safety, we focus on developing solutions that prevent or reduce the need for antibiotics while at the same time improving the quality and safety of our food.
We are here to help our customers tackle these challenges with preventive care solutions. Furthermore, we are increasing our focus on non-traditional animal health offerings, such as point-of-care diagnostic technologies, live biotherapeutics, and digital solutions.
Poultry
Through our existing and new vaccines, diagnostics, research services, technical expertise and uncompromising passion for our customers' business, we are proud to play a critical role in feeding the world with safe, affordable, abundant and sustainable quality poultry meat and eggs.
We aspire to create the future of poultry well-being through preventive care, striving to help win the battle against poultry diseases and shape the future of poultry health through disease prevention.
Our comprehensive selection of vaccines and delivery systems offer unsurpassed protection from many important poultry health challenges. These include vaccines against Marek’s Disease, Infectious Bursal Disease, Newcastle Disease, Infectious Bronchitis, Avian Influenza and many others.
As a global leader in the poultry sector and a strong advocate of prevention, we aim to continue to grow in our selected markets around the world, invest into R&D to bring innovation to our customers and form the right partnerships that will enhance our offering.
-
Poultry
Boehringer Ingelheim and Making More Health working together to support poultry farmers in Homa Bay.
-
Poultry
Poultry farming communities across the globe are grappling once again with avian influenza.
-
Animal Health
Five things you need to know to keep poultry free from outcomes of one of the most common virus affecting the animals’ immune systems.
-
Animal Health
Vincent Boue, Animal Health Director Boehringer Ingelheim Russia, talks about the new VTS Center and the poultry business in Russia.
-
Animal Health
The centre represents another development phase of our poultry business in the country.
-
Poultry Innovation Days
Animal Health
As a global leader in poultry disease prevention, Boehringer Ingelheim gathered more than 500 leaders in the industry.
-
Free-range hens (chicken) on an organic farm-639108910 .jpg